Page last updated: 2024-09-03

olmesartan medoxomil and Calcinosis

olmesartan medoxomil has been researched along with Calcinosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstrong, ZB; Boughner, DR; Drangova, M; Rogers, KA	1

Other Studies

1 other study(ies) available for olmesartan medoxomil and Calcinosis

Article	Year
Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovascular research, 2011, Apr-01, Volume: 90, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Calcinosis; Diet, Atherogenic; Disease Models, Animal; Imidazoles; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Olmesartan Medoxomil; Osteoblasts; Osteocalcin; Phenotype; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; X-Ray Microtomography	2011

Article

Year

Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model.

Cardiovascular research, 2011, Apr-01, Volume: 90, Issue:1

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Calcinosis; Diet, Atherogenic; Disease Models, Animal; Imidazoles; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Olmesartan Medoxomil; Osteoblasts; Osteocalcin; Phenotype; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Time Factors; X-Ray Microtomography

2011